The Effects of Fluconazole on Chronic Oral Candidiasis Refractory to Nystatin: Case Report

Nystatin에 반응하지 않는 만성 구강 캔디다증 증례에서 Fluconazole의 효과에 관한 보고

  • Lee, Eun-Jin (Dept. of Oral Medicine & Oral Diagnosis, School of Dentistry, Seoul National University) ;
  • Park, Won-Kyu (Dept. of Oral Medicine & Oral Diagnosis, School of Dentistry, Seoul National University) ;
  • Kho, Hong-Seop (Dept. of Oral Medicine & Oral Diagnosis, School of Dentistry, Seoul National University)
  • 이은진 (서울대학교 치과대학 구강내과.진단학교실) ;
  • 박원규 (서울대학교 치과대학 구강내과.진단학교실) ;
  • 고홍섭 (서울대학교 치과대학 구강내과.진단학교실)
  • Published : 2008.03.30

Abstract

Candidiasis, an opportunistic infectious condition caused by the genus Candida, is the most common oral fungal infection in humans. The diagnosis of oral candidiasis can often be made based on recognition of its clinical pattern, but at times there is difficulty in making a clinical diagnosis because of its various manifestations. Several antifungal medications have been developed for managing fungal infections. Despite the availability of several effective antimycotics for the treatment of oral candidiasis, failure of therapy is not uncommon due to the unique environment of the oral cavity, where the flushing effect of saliva and the cleaning action of the oral musculature tend to reduce the drug concentration to sub-therapeutic levels. In this case report, we present two patients diagnosed with chronic hyperplastic candidiasis and median rhomboid glossitis, which are known as rare forms of candidiasis. In both cases, there was a significant reduction of clinical signs and symptoms when fluconazole was prescribed after the failure of initial nystatin therapy.

구강 캔디다증은 주요 기회감염 균주인 Candida 속(屬) 진균류에 의한 감염성 질환으로 구강점막에 발생하는 진균 감염 중 가장 흔하지만, 만성증식성(chronic hyperplastic type)이나 정중능형설염(median rhomboid glossitis)과 같이 드문 형태의 경우 오진의 가능성이 있고 효과적인 치료법의 결정도 어려운 경우가 있다. 본 증례에서는 만성증식성 구강 캔디다증 및 정중능형설염으로 진단된 환자에서 nystatin 처방에 효과적으로 반응하지 않아 fluconazole을 투여하여 증상의 경감과 치유를 보인 예를 보고하고자 한다.

Keywords

References

  1. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral & maxillofacial pathology. 2nd ed., Philadelphia, 2002, WB Saunders Co., pp.189-197
  2. Shin ES, Chung SC, Kim YK, Lee SW, Kho HS. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:48-53 https://doi.org/10.1016/S1079-2104(03)00160-4
  3. Scully C, Oral and maxillofacial medicine. 1st ed., Wright, 2004, Elsevier, pp.252-268
  4. Samaranayake LP, Ferguson MM. Delivery of antifungal agents to the oral cavity. Adv Drug Deliv Rev 1994;13:161-179 https://doi.org/10.1016/0169-409X(94)90032-9
  5. Blomgren J, Berggren U, Jontell M. Fluconazole versus nystatin in the treatment of oral candidosis. Acta Odontol Scand 1998;56:202-205 https://doi.org/10.1080/00016359850142790
  6. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000;11:172-198 https://doi.org/10.1177/10454411000110020301
  7. McCullough MJ, Savage NW. Oral candidosis and the therapeutic use of antifungal agents in dentistry. Aust Dent J 2005;50:S36-39 https://doi.org/10.1111/j.1834-7819.2005.tb00383.x
  8. Mycek MJ, Harvey RA, Champe PC. Lippincott's illustrated reviews : pharmacology. 2nd ed., Hampton, 2000, Lippincott Williams & Wilkins, pp.337-344
  9. Francois IE, Aerts AM, Cammue BP, Thevissen K. Currently used antimycotics: spectrum, mode of action and resistance occurrence. Curr Drug Targets 2005;6:895-907 https://doi.org/10.2174/138945005774912744
  10. Darwazeh AMG, Lamey PJ, Lewis MAO, Samaranayake LP. Systemic fluconazole therapy and in vitro adhesion of Candida albicans to human buccal epithelial cells, J Oral Pathol Med 1991;20:17-19 https://doi.org/10.1111/j.1600-0714.1991.tb00881.x
  11. Force RW, Nahata MC. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother 1995;29:10-15 https://doi.org/10.1177/106002809502900102